Recombinant multi-species RGS6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RGS6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the RGS (regulator of G protein signaling) family of proteins, which are defined by the presence of a RGS domain that confers the GTPase-activating activity of these proteins toward certain G alpha subunits. This protein also belongs to a subfamily of RGS proteins characterized by the presence of DEP and GGL domains, the latter a G beta 5-interacting domain. The RGS proteins negatively regulate G protein signaling, and may modulate neuronal, cardiovascular, lymphocytic activities, and cancer risk. Many alternatively spliced transcript variants encoding different isoforms with long or short N-terminal domains, complete or incomplete GGL domains, and distinct C-terminal domains, have been described for this gene, however, the full-length nature of some of these variants is not known.[provided by RefSeq, Mar 2011]
The Alternative Names of target: GAP,HA117,RGS6,Regulator of G-protein signaling 6,Rgs6,S914

Target products collectionGo to RGS6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T33909-Ag-1/ GM-Tg-hg-T33909-Ag-2 Human RGS6 protein Human
GM-Tg-rg-T33909-Ag-1/ GM-Tg-rg-T33909-Ag-2 Rat RGS6 protein Rat
GM-Tg-mg-T33909-Ag-1/ GM-Tg-mg-T33909-Ag-2 Mouse RGS6 protein Mouse
GM-Tg-cynog-T33909-Ag-1/ GM-Tg-cynog-T33909-Ag-2 Cynomolgus/Rhesus macaque RGS6 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T33909-Ag-1/ GM-Tg-felg-T33909-Ag-2 Feline RGS6 protein Feline
GM-Tg-cang-T33909-Ag-1/ GM-Tg-cang-T33909-Ag-2 Canine RGS6 protein Canine
GM-Tg-bovg-T33909-Ag-1/ GM-Tg-bovg-T33909-Ag-2 Bovine RGS6 protein Bovine
GM-Tg-equg-T33909-Ag-1/ GM-Tg-equg-T33909-Ag-2 Equine RGS6 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T33909-Ag-1/ GM-Tg-hg-T33909-Ag-2; GM-Tg-rg-T33909-Ag-1/ GM-Tg-rg-T33909-Ag-2;
GM-Tg-mg-T33909-Ag-1/ GM-Tg-mg-T33909-Ag-2; GM-Tg-cynog-T33909-Ag-1/ GM-Tg-cynog-T33909-Ag-2;
GM-Tg-felg-T33909-Ag-1/ GM-Tg-felg-T33909-Ag-2; GM-Tg-cang-T33909-Ag-1/ GM-Tg-cang-T33909-Ag-2;
GM-Tg-bovg-T33909-Ag-1/ GM-Tg-bovg-T33909-Ag-2; GM-Tg-equg-T33909-Ag-1/ GM-Tg-equg-T33909-Ag-2
Products Name RGS6 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RGS6
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RGS6 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.